GlassScriptPhysician profile
Moussa Said Bazzi
NPI 1326467143
$2,094.02
in general payments reported to CMS, 2019-2025
16 companies · $309 in 2025
The $309 reported for 2025 was more than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $200 · 2020: $153 · 2021: $73.42 · 2022: $255 · 2023: $704 · 2024: $400 · 2025: $309.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,413.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,412.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $782.41 | 2022-2025 | Botox, Ubrelvy |
| Allergan, INC. | $409.74 | 2019-2022 | |
| Medtronic, INC. | $298.09 | 2023-2025 | Intellis Adaptivestim, Inceptiv |
| Truvic Medical, INC. | $100.00 | 2022 | |
| Nevro Corp. | $83.65 | 2023 | Senza |
| Nalu Medical, INC. | $75.12 | 2024 | Nalu Neurostimulation System |
| Pfizer INC. | $67.66 | 2023-2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $48.33 | 2022-2024 | Relistor |
| Boston Scientific Corporation | $41.37 | 2024-2025 | Wavewriter Alpha Prime 16, Varithena Administration Pack |
| Siemens Medical Solutions USA, INC. | $40.89 | 2020 | |
| Globus Medical, INC. | $34.26 | 2025 | Senza |
| Fidia Pharma USA INC. | $33.65 | 2024 | Hymovis |
| Lundbeck LLC | $31.31 | 2025 | Vyepti |
| Kowa Pharmaceuticals America, INC. | $17.65 | 2023 | Seglentis |
| Amneal Pharmaceuticals LLC | $15.00 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus America INC. | $14.89 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Moussa Bazzi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.